Konferenzen  >  Biowissenschaften  >  Molekularbiologie  >  Virtuelle Veranstaltung

Oxford Global

The program features case studies in vaccine development for cancer and infectious diseases, offering insights into best practices and technological advancements. Engage in focused discussions and networking with thought leaders to understand immunotherapy innovations for cancer and autoimmune diseases. The event concludes with the release of the ‘Harnessing Vaccine Technologies & Immunotherapies with Best Practice Approaches’ report, summarizing key insights and emerging trends.

Digital Marketing Executive;     Email: c.donohoe@oxfordglobal.com

Vaccine Development (Platforms), Vaccine Immunology, Vaccine Analytics Services, Vaccine Characterisation, mRNA Characterisation / Analytical Development, Vaccine Design

Biochemie und Medizinische Chemie, Toxikologie,    Biologie

Oxford Global

Join global innovators at our symposium on antibody engineering to explore cutting-edge topics such as best practice approaches, advanced therapeutics, and stability strategies. Engage with experts on AI applications and computational tools in antibody engineering. Discuss case studies on achieving stability through advanced methods. The event concludes with the ‘Harnessing Antibody Engineering with Best Practice Approaches’ report summarising key insights and trends for effective utilisation.

Digital Marketing Executive;     Email: c.donohoe@oxfordglobal.com

Antibody: Engineering/ Platforms, Discovery, Generation, Humanisation, Production and Development

Biotechnologie,    Genomforschung und Bioinformatik

The European Association for Cancer Research (EACR)

This conference aims to illuminate the intricate dynamics between ageing and cancer, fostering interdisciplinary dialogue among researchers and clinicians. By understanding the biological dimensions of cancer in ageing populations, we aspire to drive innovations in prevention, diagnosis, and treatment strategies. Ultimately, the conference seeks to catalyse collaborative efforts to confront the unique challenges posed by cancer in the ageing world, with the overarching goal of improving the quality of life and outcomes for elderly cancer patients. This conference is relevant for a diverse range of researchers, clinicians, and industry professionals. We look forward to being joined by: scientists and academics working in oncology, gerontology, genetics, and related disciplines; clinical oncologists, geriatricians, and other healthcare professionals who play a crucial role in diagnosing, treating, and supporting elderly patients with cancer; and representatives from pharmaceutical companies and biotechnology firms which develop innovative therapies and technologies to combat cancer in ageing populations. Join us online on 03 and 04 December to learn more about this fascinating topic from world-renowned speakers! Submit your abstract before 14 October and register before 11 November to secure your place.

Conference Officer: Chris Iliffe;     Tel.: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, ageing, ageing hallmarks, senescence, immunosenescence, inflammaging, aged tumour microenvironment, cancer prevention, cancer diagnosis, cancer treatment, elderly patients, treatment advances

The European Association for Cancer Research (EACR), in conjunction withAstraZeneca

Conference Officer: Hannah Barrs;     Email: hannah.barrs@eacr.org

cancer research, oncology, circulating tumour DNA, cell-free DNA, liquid biopsy, early cancer detection, clinical trial design, breast cancer, lung cancer, colorectal cancer, bladder cancer, virtual cancer research conference